Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Journal of Insurance Medicine (New York, N.Y.)
|
August 11, 2004
Metabolic syndrome
Peter Reaven
Reviews in Endocrine & Metabolic Disorders
|
May 28, 2020
Review of the veteran affairs diabetes trial: Lessons learned
Kelvin Tran, Peter Reaven
Metabolism: Clinical and Experimental
|
December 3, 2014
Dietary models of insulin resistance
James Deer, Juraj Koska, Marlies Ozias, et al.
Diabetes & Vascular Disease Research
|
April 9, 2015
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes
Juraj Koska, Michelle Sands, Camelia Burciu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 28, 2020
Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT
Jin J Zhou, Juraj Koska, Gideon Bahn, et al.
Diabetes & Vascular Disease Research
|
April 25, 2019
Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial
Jin J Zhou, Juraj Koska, Gideon Bahn, et al.
The American Journal of Managed Care
|
October 28, 2024
Cost savings from an mHealth tool for improving medication adherence
Chad Stecher, Sebastian Linnemayr, Peter Reaven, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 21, 2023
Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Stacey Uhl, Anuja Choure, Benjamin Rouse, et al.
Recent Patents on Cardiovascular Drug Discovery
|
January 28, 2012
Vascular protective effects of diabetes medications that mimic or increase glucagon-like peptide-1 activity
Angelica J Motta, Juraj Koska, Peter Reaven, et al.
Diabetes Care
|
August 8, 2018
Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial
Jin J Zhou, Dawn C Schwenke, Gideon Bahn, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Journal of Insurance Medicine (New York, N.Y.)
|
August 11, 2004
Metabolic syndrome
Peter Reaven
Reviews in Endocrine & Metabolic Disorders
|
May 28, 2020
Review of the veteran affairs diabetes trial: Lessons learned
Kelvin Tran, Peter Reaven
Metabolism: Clinical and Experimental
|
December 3, 2014
Dietary models of insulin resistance
James Deer, Juraj Koska, Marlies Ozias, et al.
Diabetes & Vascular Disease Research
|
April 9, 2015
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes
Juraj Koska, Michelle Sands, Camelia Burciu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 28, 2020
Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT
Jin J Zhou, Juraj Koska, Gideon Bahn, et al.
Diabetes & Vascular Disease Research
|
April 25, 2019
Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial
Jin J Zhou, Juraj Koska, Gideon Bahn, et al.
The American Journal of Managed Care
|
October 28, 2024
Cost savings from an mHealth tool for improving medication adherence
Chad Stecher, Sebastian Linnemayr, Peter Reaven, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 21, 2023
Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Stacey Uhl, Anuja Choure, Benjamin Rouse, et al.
Recent Patents on Cardiovascular Drug Discovery
|
January 28, 2012
Vascular protective effects of diabetes medications that mimic or increase glucagon-like peptide-1 activity
Angelica J Motta, Juraj Koska, Peter Reaven, et al.
Diabetes Care
|
August 8, 2018
Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial
Jin J Zhou, Dawn C Schwenke, Gideon Bahn, et al.
Page
of 5